This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

GEM - cardiovascular risk educational module part one

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Cardiovascular Risk Module - Part One

Points to consider when calculating cardiovascular risk:

1) what is the relationship between cardiovascular risk and coronary heart disease risk

2) Cardiovascular Risk tables are used in the primary prevention of cardiovascular disease. QRISK has outlined situations when they consider cardiovascular risk not appropriate because the inviduals are already of High Risk (cardiovascular risk > 10% over the next 10 years). Can you identify (or suggest) the groups chosen?

For more information....GPnotebook reference.

3) What are the suggested targets for lipid lowering in patients of high cardiovascular risk?

For more information..GPnotebook reference

4) Guidelines have identified patients with diabetes with regards to high cardiovascular risk. Statin treatment has been suggested for this population.

For more information...GPnotebook reference

The principle evidence relating to use of statin treatment in patients with diabetes is based on two trials (click here for more information CARDS and HPS). How does this trial based data compare to the suggested treatment groups in the guidelines?

5) microalbuminuria is a risk factor for cardiovascular disease. How does microalbuminuria affect cardiovascular risk

For more information ..GPnotebook reference

6) metabolic syndrome also increases the risk of cardiovascular disease. What is metabolic syndrome?

For more information...GPnotebook reference


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page